Degenerative Disc Research Study: ASCEND: A Randomized, Double Blind, Sham Controlled, Multi Center Phase I/II Trial to Evaluate the Safety and Effectiveness of VIA Disc NP, a Supplement for Degenerated Intervertebral Discs.

The purpose of this research study is to evaluate the safety and effectiveness of VIA Disc NP in participants with symptomatic lumbar discogenic pain due to degenerative disc disease compared to a sham needle injection. The sham needle injection group is needed to compare whether VIA Disc NP actually helps symptomatic lumbar discogenic pain. Participants who receive the sham needle injection will have a procedure but will not be injected with VIA Disc NP and the needle will only go into their muscle. Participants will not know whether they receive the sham needle injection and will have the potential to receive VIA Disc NP treatment during the study.